Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods.
暂无分享,去创建一个
[1] Ichiro Katayama,et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. , 2015, Biomaterials.
[2] Parminder Singh,et al. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs. , 2015, Vaccine.
[3] G. Carnell,et al. Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis , 2015, Front. Immunol..
[4] D. McAllister,et al. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature , 2015, Drug Delivery and Translational Research.
[5] A. Hill,et al. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. , 2015, The Lancet. Infectious diseases.
[6] Mark R Prausnitz,et al. Development of a thermostable microneedle patch for influenza vaccination. , 2015, Journal of pharmaceutical sciences.
[7] Carl W Davis,et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans , 2014, Proceedings of the National Academy of Sciences.
[8] C. O’Mahony,et al. Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route , 2014, Scientific Reports.
[9] E. Montomoli,et al. Discordant Correlation between Serological Assays Observed When Measuring Heterosubtypic Responses against Avian Influenza H5 and H7 Viruses in Unexposed Individuals , 2014, BioMed research international.
[10] Mark R Prausnitz,et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. , 2014, Vaccine.
[11] Conor O'Mahony,et al. Structural characterization and in-vivo reliability evaluation of silicon microneedles , 2014, Biomedical Microdevices.
[12] Conor O'Mahony,et al. Production of dissolvable microneedles using an atomised spray process: effect of microneedle composition on skin penetration. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] R. Rappuoli,et al. Correlates of protection against influenza infection in humans--on the path to a universal vaccine? , 2013, Current opinion in immunology.
[14] P. Dormitzer,et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. , 2013, Vaccine.
[15] S. Draper,et al. Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects , 2013, Vaccine.
[16] P. Lydon,et al. Projections of costs, financing, and additional resource requirements for low- and lower middle-income country immunization programs over the decade, 2011-2020. , 2013, Vaccine.
[17] E. Böttcher-Friebertshäuser,et al. The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes , 2013, Journal of molecular and genetic medicine : an international journal of biomedical research.
[18] D. Rhodes,et al. Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability , 2012, BMC Biotechnology.
[19] Mark R. Prausnitz,et al. Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine , 2012, PloS one.
[20] Conor O'Mahony,et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[21] Mark R. Prausnitz,et al. Local Response to Microneedle-Based Influenza Immunization in the Skin , 2012, mBio.
[22] I. Frazer,et al. Rapid kinetics to peak serum antibodies is achieved following influenza vaccination by dry-coated densely packed microprojections to skin. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[23] Adolfo García-Sastre,et al. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses , 2012, Proceedings of the National Academy of Sciences.
[24] E. R. van den Heuvel,et al. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay. , 2012, Vaccine.
[25] J. Stockman,et al. Dissolving polymer microneedle patches for influenza vaccination , 2012 .
[26] A. Steven,et al. Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines. , 2011, Vaccine.
[27] A. Crean,et al. Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice , 2011, PloS one.
[28] H. McShane,et al. Tuberculosis vaccines in clinical trials , 2011, Expert review of vaccines.
[29] David M Martin,et al. Drug-eluting stents for coronary artery disease: a review. , 2011, Medical engineering & physics.
[30] N. Nundy,et al. Incremental costs of introducing jet injection technology for delivery of routine childhood vaccinations: comparative analysis from Brazil, India, and South Africa. , 2011, Vaccine.
[31] J. Yewdell,et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection , 2011, The Journal of experimental medicine.
[32] H. L. Glansbeekb,et al. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay , 2011 .
[33] Mark R Prausnitz,et al. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[34] Conor O'Mahony,et al. In-vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. , 2010, Journal of biomedical optics.
[35] T. Prow,et al. The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. , 2010, Biomaterials.
[36] Mark R. Prausnitz,et al. Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization , 2010, Journal of Virology.
[37] Mark R. Prausnitz,et al. Dissolving Polymer Microneedle Patches for Influenza Vaccination , 2010, Nature Medicine.
[38] Mark R Prausnitz,et al. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[39] A. Hill,et al. Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine Vectors at Supraphysiological Temperatures in Carbohydrate Glass , 2010, Science Translational Medicine.
[40] R. Rappuoli,et al. Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus , 2010, Science Translational Medicine.
[41] A. Folgori,et al. Prime-boost vectored malaria vaccines: Progress and prospects , 2010, Human vaccines.
[42] A. Hill,et al. Alcock Vectors at Supraphysiological Temperatures in Carbohydrate Glass Long-Term Thermostabilization of Live Poxviral and Adenoviral Vaccine , 2010 .
[43] M. Prausnitz,et al. Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage , 2010, Pharmaceutical Research.
[44] J. Matriano,et al. Parathyroid Hormone (1-34)-Coated Microneedle Patch System: Clinical Pharmacokinetics and Pharmacodynamics for Treatment of Osteoporosis , 2010, Pharmaceutical Research.
[45] M. Prausnitz,et al. Stabilization of Influenza Vaccine Enhances Protection by Microneedle Delivery in the Mouse Skin , 2009, PloS one.
[46] P. van Damme,et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. , 2009, Vaccine.
[47] Jung-Hwan Park,et al. Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.
[48] Mark R Prausnitz,et al. Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles , 2008, Advanced materials.
[49] G. Glenn,et al. Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch , 2008, Influenza and other respiratory viruses.
[50] R. Hutubessy,et al. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. , 2008, Bulletin of the World Health Organization.
[51] R. Weiss,et al. A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies , 2007, Influenza and other respiratory viruses.
[52] Yong-Kyu Yoon,et al. Polymer particle-based micromolding to fabricate novel microstructures , 2007, Biomedical microdevices.
[53] Mark R. Prausnitz,et al. Coating Formulations for Microneedles , 2007, Pharmaceutical Research.
[54] Mark R Prausnitz,et al. Coated microneedles for transdermal delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[55] N. Wilke,et al. Process optimization and characterization of silicon microneedles fabricated by wet etch technology , 2005, Microelectron. J..
[56] Jung-Hwan Park,et al. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[57] P. Perrin,et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. , 2005, Immunity.
[58] R. Nuzzo,et al. A method for filling complex polymeric microfluidic devices and arrays. , 2001, Analytical chemistry.
[59] Y. Hutin,et al. Injection safety: a global challenge. , 1999, Bulletin of the World Health Organization.
[60] Wagner,et al. Stabilization of gene delivery systems by freeze-drying. , 1997, International journal of pharmaceutics.
[61] V. Seagroatt,et al. An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. , 1977, Journal of biological standardization.
[62] V. Seagroatt,et al. Application of an improved single-radial-immunodiffusion technique for the assay of haemagglutinin antigen content of whole virus and subunit influenza vaccines. , 1977, Developments in biological standardization.